Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

Lynda Anne Szczech, Donald R. Hoover, Joseph G. Feldman, Mardge H. Cohen, Stephen J Gange, Lisa Goozé, Nancy R. Rubin, Mary A. Young, Xiaotao Cai, Qiuhu Shi, Wei Gao, Kathryn Anastos

Research output: Contribution to journalArticle

Abstract

Background. The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described. Methods. This analysis includes 2038 human immunodeficiency virus (HIV)-infected women from the Women's Interagency HIV Study. Time to the development of a new AIDS-defining illness (ADI) and death was modeled using proportional hazards regression before the widespread availability of HAART and after initiation of HAART. Results. Of the 2038 subjects, the 14.1% of women with proteinuria had lower CD4 lymphocyte counts and higher viral loads (P <.0001 for all) at baseline and before initiation of HAART. Before the widespread availability of HAART, proteinuria was associated with an increased risk for development of ADI (hazard ratio [HR], 1.37; P = .005), and proteinuria and an elevated creatinine level were both associated with an increased risk of death (for proteinuria: HR, 1.35 [P = .04]; for creatinine: HR, 1.72 per decrease in the inverse unit [P = .02]). Among women initiating HAART, an elevated creatinine level remained associated with an increased risk of development of ADI (HR, 1.54 per decrease in the inverse unit; P = .03), and proteinuria and an elevated creatinine level were associated with an increased risk of death (for proteinuria: HR, 2.07 [P = .005]; for creatinine: HR, 1.96 per decrease in the inverse unit [P = .04]). Conclusions. Proteinuria and an elevated creatinine level were associated with an increased risk of death and development of ADI. These associations may reflect the direct role of the kidney in modulating HIV disease, or they may act as markers of greater comorbidity.

Original languageEnglish (US)
Pages (from-to)1199-1206
Number of pages8
JournalClinical Infectious Diseases
Volume39
Issue number8
DOIs
StatePublished - Oct 15 2004

Fingerprint

Proteinuria
Highly Active Antiretroviral Therapy
Creatinine
HIV
Kidney
Acquired Immunodeficiency Syndrome
Therapeutics
Virus Diseases
CD4 Lymphocyte Count
Viral Load
Comorbidity

ASJC Scopus subject areas

  • Immunology

Cite this

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. / Szczech, Lynda Anne; Hoover, Donald R.; Feldman, Joseph G.; Cohen, Mardge H.; Gange, Stephen J; Goozé, Lisa; Rubin, Nancy R.; Young, Mary A.; Cai, Xiaotao; Shi, Qiuhu; Gao, Wei; Anastos, Kathryn.

In: Clinical Infectious Diseases, Vol. 39, No. 8, 15.10.2004, p. 1199-1206.

Research output: Contribution to journalArticle

Szczech, LA, Hoover, DR, Feldman, JG, Cohen, MH, Gange, SJ, Goozé, L, Rubin, NR, Young, MA, Cai, X, Shi, Q, Gao, W & Anastos, K 2004, 'Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy', Clinical Infectious Diseases, vol. 39, no. 8, pp. 1199-1206. https://doi.org/10.1086/424013
Szczech, Lynda Anne ; Hoover, Donald R. ; Feldman, Joseph G. ; Cohen, Mardge H. ; Gange, Stephen J ; Goozé, Lisa ; Rubin, Nancy R. ; Young, Mary A. ; Cai, Xiaotao ; Shi, Qiuhu ; Gao, Wei ; Anastos, Kathryn. / Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. In: Clinical Infectious Diseases. 2004 ; Vol. 39, No. 8. pp. 1199-1206.
@article{ef12b74f9fea4eff9a9798463ad06175,
title = "Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy",
abstract = "Background. The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described. Methods. This analysis includes 2038 human immunodeficiency virus (HIV)-infected women from the Women's Interagency HIV Study. Time to the development of a new AIDS-defining illness (ADI) and death was modeled using proportional hazards regression before the widespread availability of HAART and after initiation of HAART. Results. Of the 2038 subjects, the 14.1{\%} of women with proteinuria had lower CD4 lymphocyte counts and higher viral loads (P <.0001 for all) at baseline and before initiation of HAART. Before the widespread availability of HAART, proteinuria was associated with an increased risk for development of ADI (hazard ratio [HR], 1.37; P = .005), and proteinuria and an elevated creatinine level were both associated with an increased risk of death (for proteinuria: HR, 1.35 [P = .04]; for creatinine: HR, 1.72 per decrease in the inverse unit [P = .02]). Among women initiating HAART, an elevated creatinine level remained associated with an increased risk of development of ADI (HR, 1.54 per decrease in the inverse unit; P = .03), and proteinuria and an elevated creatinine level were associated with an increased risk of death (for proteinuria: HR, 2.07 [P = .005]; for creatinine: HR, 1.96 per decrease in the inverse unit [P = .04]). Conclusions. Proteinuria and an elevated creatinine level were associated with an increased risk of death and development of ADI. These associations may reflect the direct role of the kidney in modulating HIV disease, or they may act as markers of greater comorbidity.",
author = "Szczech, {Lynda Anne} and Hoover, {Donald R.} and Feldman, {Joseph G.} and Cohen, {Mardge H.} and Gange, {Stephen J} and Lisa Gooz{\'e} and Rubin, {Nancy R.} and Young, {Mary A.} and Xiaotao Cai and Qiuhu Shi and Wei Gao and Kathryn Anastos",
year = "2004",
month = "10",
day = "15",
doi = "10.1086/424013",
language = "English (US)",
volume = "39",
pages = "1199--1206",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

AU - Szczech, Lynda Anne

AU - Hoover, Donald R.

AU - Feldman, Joseph G.

AU - Cohen, Mardge H.

AU - Gange, Stephen J

AU - Goozé, Lisa

AU - Rubin, Nancy R.

AU - Young, Mary A.

AU - Cai, Xiaotao

AU - Shi, Qiuhu

AU - Gao, Wei

AU - Anastos, Kathryn

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Background. The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described. Methods. This analysis includes 2038 human immunodeficiency virus (HIV)-infected women from the Women's Interagency HIV Study. Time to the development of a new AIDS-defining illness (ADI) and death was modeled using proportional hazards regression before the widespread availability of HAART and after initiation of HAART. Results. Of the 2038 subjects, the 14.1% of women with proteinuria had lower CD4 lymphocyte counts and higher viral loads (P <.0001 for all) at baseline and before initiation of HAART. Before the widespread availability of HAART, proteinuria was associated with an increased risk for development of ADI (hazard ratio [HR], 1.37; P = .005), and proteinuria and an elevated creatinine level were both associated with an increased risk of death (for proteinuria: HR, 1.35 [P = .04]; for creatinine: HR, 1.72 per decrease in the inverse unit [P = .02]). Among women initiating HAART, an elevated creatinine level remained associated with an increased risk of development of ADI (HR, 1.54 per decrease in the inverse unit; P = .03), and proteinuria and an elevated creatinine level were associated with an increased risk of death (for proteinuria: HR, 2.07 [P = .005]; for creatinine: HR, 1.96 per decrease in the inverse unit [P = .04]). Conclusions. Proteinuria and an elevated creatinine level were associated with an increased risk of death and development of ADI. These associations may reflect the direct role of the kidney in modulating HIV disease, or they may act as markers of greater comorbidity.

AB - Background. The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described. Methods. This analysis includes 2038 human immunodeficiency virus (HIV)-infected women from the Women's Interagency HIV Study. Time to the development of a new AIDS-defining illness (ADI) and death was modeled using proportional hazards regression before the widespread availability of HAART and after initiation of HAART. Results. Of the 2038 subjects, the 14.1% of women with proteinuria had lower CD4 lymphocyte counts and higher viral loads (P <.0001 for all) at baseline and before initiation of HAART. Before the widespread availability of HAART, proteinuria was associated with an increased risk for development of ADI (hazard ratio [HR], 1.37; P = .005), and proteinuria and an elevated creatinine level were both associated with an increased risk of death (for proteinuria: HR, 1.35 [P = .04]; for creatinine: HR, 1.72 per decrease in the inverse unit [P = .02]). Among women initiating HAART, an elevated creatinine level remained associated with an increased risk of development of ADI (HR, 1.54 per decrease in the inverse unit; P = .03), and proteinuria and an elevated creatinine level were associated with an increased risk of death (for proteinuria: HR, 2.07 [P = .005]; for creatinine: HR, 1.96 per decrease in the inverse unit [P = .04]). Conclusions. Proteinuria and an elevated creatinine level were associated with an increased risk of death and development of ADI. These associations may reflect the direct role of the kidney in modulating HIV disease, or they may act as markers of greater comorbidity.

UR - http://www.scopus.com/inward/record.url?scp=19944434212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944434212&partnerID=8YFLogxK

U2 - 10.1086/424013

DO - 10.1086/424013

M3 - Article

C2 - 15486845

AN - SCOPUS:19944434212

VL - 39

SP - 1199

EP - 1206

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 8

ER -